This result is in agreement with our CHK1 phosphorylation results which demonstrate a decreased CHK1 phosphorylation at Ser317/Ser345 in the cisplatin-treated HTB182 and CRL5985 lung cancer cells in the presence of caffeine. This evidence concerns the gene CHEK1 and lung carcinoma.